Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?

Simple item page
dc.contributor.authorSabio, Jose Mario
dc.contributor.authoraffiliation[Sabio, Jose Mario] Hosp Virgen Nieves, Dept Internal Med, Syst Autoimmune Dis Unit, Granada, Spain
dc.date.accessioned2025-01-07T14:19:57Z
dc.date.available2025-01-07T14:19:57Z
dc.date.issued2022-04-01
dc.identifier.doi10.1136/annrheumdis-2020-217575
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/early/2020/04/26/annrheumdis-2020-217575.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/26299
dc.identifier.wosID769314000005
dc.issue.number4
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.subjectautoimmune diseases
dc.subjectglucocorticoids
dc.subjectimmune system diseases
dc.titleWithdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?
dc.typeletter
dc.type.hasVersionVoR
dc.volume.number81
dc.wostypeLetter

Files

Collections

SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía